NSEUpdates9 Jul 2026 · 9 Jul 2026, 08:01 pm

Updates

Blue Jet Healthcare Limited · BLUEJET

✦ AI SummaryFundraise

Blue Jet Healthcare Limited has informed the Exchange regarding the Investment and Finance Committee meeting held on July 9, 2026, where the committee approved the closure of the qualified institutions placement of equity shares, allocation of shares, and adoption of the Placement Document.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk6/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Blue Jet Healthcare Limited has informed the Exchange regarding 'Investment and Finance Committee meeting held today, i.e. July 9, 2026'.

Attachments (1)

📄

BLUEJET_09072026200129_SE_Announcement_Issue_close_Final_sign.pdf

pdf

Download →
View document text
July 9, 2026 The Manager The Manager BSE Limited National Stock Exchange of India Limited P. J Towers, Dalal Street, Fort "Exchange Plaza", C-1, Block G, Mumbai – 400 001 Bandra-Kurla Complex, Bandra (E), Scrip Code: 544009 Mumbai 400 051 Symbol: BLUEJET Dear Madam / Sir Sub: Qualified institutions placement of equity shares of face value of ₹2 each (the “Equity Shares”) by Blue Jet Healthcare Limited (the “Company”) under the provisions of Chapter VI of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (the “SEBI ICDR Regulations”), and Sections 42 and 62 of the Companies Act, 2013 (including the rules made thereunder), as amended (the “Issue”). Further to our earlier intimation(s) on the captioned subject, we wish to inform you that the Investment and Finance Committee at its meeting held today, i.e. July 9, 2026 has, inter alia, passed the following resolutions: a. Approving the closure of the Issue today (i.e. July 9, 2026) pursuant to the receipt of application forms and the funds in the escrow account(s) from the eligible qualified institutional buyers in accordance with the terms of the Issue; b. Determining and approving the allocation of 15,810,276 Equity Shares at an Issue price of ₹506.00 per Equity Share (including a premium of ₹ 504.00 per Equity Share) which takes into account a discount of ₹ 25.70/- per equity share (4.83% of the floor price) to the floor price of ₹ 531.70/-, as permitted in terms of Regulation 176 of Chapter VI of the SEBI ICDR Regulations, for the Equity Shares to be allotted to the eligible qualified institutional buyers in the Issue; and c. Approving and adopting the Placement Document dated July 9, 2026. d. Approving and finalizing the confirmation of allocation note to be sent to eligible qualified institutional buyers, intimating them of the allocation of Equity Shares pursuant to the Issue; and The meeting of the Investment and Finance Committee commenced at 7:30 p.m. and concluded at 7:45 p.m. We request you to kindly take this on record, and the same be treated as compliance under the applicable regulations of the Securities and Exchange Board of India (Listing Obligations Disclosure Requirements) Regulations, 2015, as amended. Copy of the placement document is also being made available on the website of the Company at www.bluejethealthcare.com Thanking you Yours faithfully For Blue Jet Healthcare Limited Sweta Poddar Company Secretary and Compliance Officer Membership No: F12287